2025

Exploring morphological and microstructural signatures across the Alzheimer’s spectrum and risk factors. (Bussy A. et al., 2025)

2025, Publication scientifique /

Citation : Bussy, A., Patel, R., Parent, O., Salaciak, A., Bedford, S. A., Farzin, S., Tullo, S., Picard, C., Villeneuve, S., Poirier, J., Breitner, J. C., Devenyi, G. A., PREVENT-AD Research Group, Tardif, C. L., & Chakravarty, M. M. (2025). Exploring morphological and microstructural signatures across the Alzheimer’s spectrum and risk factors. Neurobiology of aging, […]

Exploring morphological and microstructural signatures across the Alzheimer’s spectrum and risk factors. (Bussy A. et al., 2025) Read More »

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. (Wiesman AI. et al., 2025)

2025, Publication scientifique /

Citation : Wiesman, A. I., Madge, V., Fon, E. A., Dagher, A., Collins, D. L., Baillet, S., & PREVENT-AD Research Group and Quebec Parkinson Network (2025). Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. Brain : a journal of neurology, 148(3), 875–885. https://doi.org/10.1093/brain/awae295. Full text : Here Associations between neuromelanin depletion and

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. (Wiesman AI. et al., 2025) Read More »

Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. (Tremblay C. et Al., 2025)

2025, Publication scientifique /

Citation : Tremblay, C., Rahayel, S., Pastor-Bernier, A., St-Onge, F., Vo, A., Rheault, F., Daneault, V., Morys, F., Rajah, N., Villeneuve, S., Dagher, A., PREVENT-AD Research Group , & Alzheimer’s Disease Neuroimaging Initiative (ADNI) (2025). Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. Brain communications, 7(2), fcaf099. https://doi.org/10.1093/braincomms/fcaf099 Full text

Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. (Tremblay C. et Al., 2025) Read More »

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker CS. et al., 2025)

2025, Publication scientifique /

Citation : Walker, C. S., Noriega de la Colina, A. E., Li, L., Boulanger, C., Thovinakere, N., Noly-Gandon, A., Barnoin, G., Bennett, M., Caplan, J., Côté, L., Elbaz, S., Bao, S. F. K., Kara, R., Lavoie, N., Nguyen, M., Otaner, F., Pallett-Wiesel, H., Piché, J. V., Powers, A., Ricciardelli, S., … PREVENT-AD Research Group (2025).

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker CS. et al., 2025) Read More »

Depressive Symptoms and Amyloid Pathology. (Wiels WA. et al., 2025)

2025, Publication scientifique /

Citation : Wiels, W. A., Oomens, J. E., Engelborghs, S., Baeken, C., von Arnim, C. A. F., Boada, M., Didic, M., Dubois, B., Fladby, T., van der Flier, W. M., Frisoni, G. B., Fröhlich, L., Gill, K. D., Grimmer, T., Hildebrandt, H., Hort, J., Itoh, Y., Iwatsubo, T., Klimkowicz-Mrowiec, A., Lee, D. Y., … Zettergren,

Depressive Symptoms and Amyloid Pathology. (Wiels WA. et al., 2025) Read More »

Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window. (Yakoub Y. et Al., 2025)

2025, Publication scientifique /

Citation : Yakoub, Y., Gonzalez-Ortiz, F., Ashton, N. J., Déry, C., Strikwerda-Brown, C., St-Onge, F., Ourry, V., Schöll, M., Geddes, M. R., Ducharme, S., Montembeault, M., Rosa-Neto, P., Soucy, J. P., Breitner, J. C. S., Zetterberg, H., Blennow, K., Poirier, J., Villeneuve, S., & PREVENT−AD Research Group (2025). Plasma p-tau217 identifies cognitively normal older adults

Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window. (Yakoub Y. et Al., 2025) Read More »

Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE 4 Carriers. (Fisher L., et al., 2025)

2025, Publication scientifique /

Citation : Fischer, L., Molloy, E. N., Pichet Binette, A., Vockert, N., Marquardt, J., Pacha Pilar, A., Kreissl, M. C., Remz, J., Tremblay-Mercier, J., Poirier, J., Rajah, M. N., Villeneuve, S., PREVENT-AD Research Group, & Maass, A. (2025). Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE4 Carriers. The

Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE 4 Carriers. (Fisher L., et al., 2025) Read More »

Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. (Ao J. et Al., 2025)

2025, Publication scientifique /

Citation : Ao, J., Picard, C., Auld, D., Zetterberg, H., Brinkmalm, A., Blennow, K., Villeneuve, S., Breitner, J. C. S., Poirier, J., & PREVENT-AD research group (2025). Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. Molecular psychiatry, 10.1038/s41380-024-02884-z. Advance online publication. https://doi.org/10.1038/s41380-024-02884-z Full text

Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease. (Ao J. et Al., 2025) Read More »

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker et al., 2025)

2025, Publication scientifique /

Citation : Walker, C. S., Noriega de la Colina, A. E., Li, L., Boulanger, C., Thovinakere, N., Noly-Gandon, A., Barnoin, G., Bennett, M., Caplan, J., Côté, L., Elbaz, S., Bao, S. F. K., Kara, R., Lavoie, N., Nguyen, M., Otaner, F., Pallett-Wiesel, H., Piché, J. V., Powers, A., Ricciardelli, S., … PREVENT-AD Research Group (2025).

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer’s disease. (Walker et al., 2025) Read More »